UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis

Frontiers in oncology, 2022-04, Vol.12, p.841418-841418

2022

Volltextzugriff (PDF)

Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial)

BMC cancer, 2018-01, Vol.18 (1), p.15-15, Article 15

2018

Volltextzugriff (PDF)

New concepts in neurology education: successful implementation of flipped classroom lectures

Neurological research and practice, 2022-08, Vol.4 (1), p.31-31, Article 31

2022

Volltextzugriff (PDF)

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1452-1464

2012

Volltextzugriff (PDF)

Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma

Cancers, 2020-10, Vol.12 (10), p.2964

2020

Volltextzugriff (PDF)

Residents as teachers in Neurology: a Germany-wide survey on the involvement of neurological residents in clinical teaching

Neurological research and practice, 2022-05, Vol.4 (1), p.17-17, Article 17

2022

Volltextzugriff (PDF)

Image Analysis Reveals Microstructural and Volumetric Differences in Glioblastoma Patients with and without Preoperative Seizures

Cancers, 2020-04, Vol.12 (4), p.994

2020

Volltextzugriff (PDF)

The influence of postoperative infections on the survival of glioma patients

Journal of the neurological sciences, 2021-10, Vol.429, p.118456, Article 118456

2021

Volltextzugriff (PDF)

Kritische Betrachtung der Leitlinie der Europäischen Gesellschaft für Neuroonkologie (EANO) zur Diagnostik und Behandlung von adulten astrozytären und oligodendroglialen Gliomen

Strahlentherapie und Onkologie, 2017-11, Vol.193 (11), p.984-988

2017

Volltextzugriff (PDF)

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (34), p.1-e2206208119

2022

Volltextzugriff (PDF)

Resolving spatial response heterogeneity in glioblastoma

European journal of nuclear medicine and molecular imaging, 2024-06

2024

Volltextzugriff (PDF)

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T H 17 lineage in humans

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (34)

2022

Volltextzugriff (PDF)

Not Available

Strahlentherapie und Onkologie, 2016-09, Vol.192 (9), p.672-674

2016

Volltextzugriff (PDF)

Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability

Neurosurgery, 2018-12, Vol.83 (6), p.1241-1248

2018

Volltextzugriff (PDF)

A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers

Current treatment options in oncology, 2019-09, Vol.20 (10), p.71-71, Article 71

2019

Volltextzugriff (PDF)

RTHP-26. FEASIBILITY OF A CONCOMITANT ADMINISTRATION OF ALTERNATING ELECTRIC FIELDS AND RADIOTHERAPY – A PLANNING STUDY

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi224-vi224

2017

Volltextzugriff (PDF)

Neurological teaching in times of crisis

GMS journal for medical education, 2020-01, Vol.37 (7), p.Doc69-Doc69

2020

Volltextzugriff (PDF)

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii71-vii71

2022

Volltextzugriff (PDF)

Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae106

2024

Volltextzugriff (PDF)

NCOG-10. FACTORS INFLUENCING NEUROCOGNITIVE FUNCTION IN PATIENTS WITH NEUROEPITHELIAL TUMORS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi139-vi140

2017

Volltextzugriff (PDF)

Correction to: Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection

Annals of surgical oncology, 2018-12, Vol.25 (Suppl 3), p.989-989

2018

Volltextzugriff (PDF)

Publisher Correction: Factors influencing neurocognitive function in patients with neuroepithelial tumors

Scientific reports, 2018-03, Vol.8 (1), p.4274-1, Article 4274

2018

Volltextzugriff (PDF)

Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up

Cancers, 2019-11, Vol.11 (12), p.1884

2019

Volltextzugriff (PDF)

Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdad171-vdad171

2024

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaBrain Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis

Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial)

New concepts in neurology education: successful implementation of flipped classroom lectures

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma

Residents as teachers in Neurology: a Germany-wide survey on the involvement of neurological residents in clinical teaching

Image Analysis Reveals Microstructural and Volumetric Differences in Glioblastoma Patients with and without Preoperative Seizures

The influence of postoperative infections on the survival of glioma patients

Kritische Betrachtung der Leitlinie der Europäischen Gesellschaft für Neuroonkologie (EANO) zur Diagnostik und Behandlung von adulten astrozytären und oligodendroglialen Gliomen

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Resolving spatial response heterogeneity in glioblastoma

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T H 17 lineage in humans

Not Available

Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability

A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers

RTHP-26. FEASIBILITY OF A CONCOMITANT ADMINISTRATION OF ALTERNATING ELECTRIC FIELDS AND RADIOTHERAPY – A PLANNING STUDY

Neurological teaching in times of crisis

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology

NCOG-10. FACTORS INFLUENCING NEUROCOGNITIVE FUNCTION IN PATIENTS WITH NEUROEPITHELIAL TUMORS

Correction to: Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection

Publisher Correction: Factors influencing neurocognitive function in patients with neuroepithelial tumors

Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up

Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

Aktive Filter

Suchergebnisse filtern